Mesnex
Mesna
- 400 mg/ 4 ml IV Injection
Biotech and Oncology
Mesnex is indicated as a prophylactic agent in preventing ifosfamide-induced hemorrhagic cystitis (syndrome of bleeding and irritation of the bladder). It is also indicated in preventing high dose cyclophospamide-induced hemorrhagic cystitis.
